Nura Bio
Madelyn Cueva started their work experience in 2004 as an Associate Scientist at Amgen, where they worked until 2015. Madelyn then joined Gilead Sciences as a Senior Associate Scientist from 2015 to 2021. Currently, they are working as a Scientist II at Nura Bio starting from June 2021.
Madelyn Cueva holds a Master's degree in Biology, General from San Francisco State University. The exact start and end years of their education are not provided.
Nura Bio
Nura Bio revolutionizes the treatment of neurological diseases with novel, life-changing neuroprotective medicines. Nura Bio was conceived in 2018 by The Column Group and its scientific founders.